Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Item 9 Labs (INLB) Non-Current Deffered Revenue (2021 - 2023)

Item 9 Labs' Non-Current Deffered Revenue history spans 3 years, with the latest figure at $413359.0 for Q2 2023.

  • For Q2 2023, Non-Current Deffered Revenue rose 19.52% year-over-year to $413359.0; the TTM value through Jun 2023 reached $413359.0, up 19.52%, while the annual FY2022 figure was $335859.0, 48.79% down from the prior year.
  • Non-Current Deffered Revenue reached $413359.0 in Q2 2023 per INLB's latest filing, down from $419608.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $655851.0 in Q3 2021 to a low of $330861.0 in Q4 2022.
  • Average Non-Current Deffered Revenue over 3 years is $412262.6, with a median of $379607.0 recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: crashed 48.79% in 2022, then rose 21.32% in 2023.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $450853.0 in 2021, then fell by 26.61% to $330861.0 in 2022, then rose by 24.93% to $413359.0 in 2023.
  • Per Business Quant, the three most recent readings for INLB's Non-Current Deffered Revenue are $413359.0 (Q2 2023), $419608.0 (Q1 2023), and $330861.0 (Q4 2022).